AI assistant
Orchid Pharma Limited — Call Transcript 2023
May 8, 2023
60526_rns_2023-05-08_e1869229-757c-4d18-a617-be9fb9af8d1e.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [552 x 66] intentionally omitted <==
May 08, 2023
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai400001
Symbol: ORCHPHARMA
Scrip Code: 524372
Subject : Intimation of Schedule of Analyst/ Investor Call – Orchid Pharma Limited (“the Company”)
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an Analyst /Investor Conference Call is scheduled to be held on Thursday, May 11, 2023 at 4:00 P.M. (IST) to discuss the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023.
The schedule of the Investor Conference Call is enclosed herewith. The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com
Note: The schedule may undergo change due to exigencies on the part of Investors/Analysts/Company.
You are requested to take the above on record.
Thanking You, For Orchid Pharma Limited
MARIN Digitally signed by MARINA PETER A PETER Date: 2023.05.08 15:09:52 +05'30'
Marina Peter Company Secretary & Compliance Officer Encl. as above
==> picture [552 x 60] intentionally omitted <==
CONFERENCE CALL
Hosted by Nuvama Wealth Management
ORCHID PHARMA
India Equity Research May 8, 2023
Nuvama Wealth Management is hosting a conference call with the management of Orchid Pharma to discuss the Company’s Q4FY23 financial results on Thursday, May 11, 2023 at 4.00 PM IST.
Mr. Manish Dhanuka, Managing Director, Mr. Mridul Dhanuka, Whole Time Director & Mr. Sunil Kumar Gupta, Chief Financial Officer, will represent Orchid Pharma Ltd. on the call.
Details of the conference call are as under:
Time : 4.00 PM IST on Thursday, May 11, 2023 Conference dial-in: India : Mumbai : Primary access number + 91 22 6280 1578 +91 22 7115 8091 Call leader Mr. Kunal Randeria
For further information, please contact:
Kunal Randeria
Director – Research, Nuvama Wealth Management Ltd. E-mail: [email protected]
Express Join with DiamondPass™
Nuvama Research is also available on research.nuvama.com, Bloomberg – NUVA, Thomson Reuters and Factset
Nuvama Wealth Management Ltd.